Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Exicure Inc
XCUR
Healthcare
Biotechnology
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company is into exploring strategic alternatives to maximize stockholder value. It is engaging in a broader exploration of strategic alternatives. This effort involves exploring growth through transactions with potential partners that see...
opportunity in joining an existing, publicly traded organization. The Company is exploring transactions in industries unrelated to its historical operations. It does not generate any revenues. It wholly owned subsidiary is Exicure Operating Company that holds all material assets and conducts all business activities and operations of the Company.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:XCUR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(280)
•••
whytestocks
X
Post by
whytestocks
on Nov 22, 2024 11:45am
Exicure Inc. (NASDAQ: XCUR) Near the Top of Equities by Perc
Breaking News: $XCUR Exicure Inc. (NASDAQ: XCUR) Near the Top of Equities by Percentage Gain on 11/22Exicure, Inc. (NASDAQ: XCUR) is one of today's top gainers. The company's shares have moved
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 21, 2024 11:15am
XCUR...todays low was $8.43 after ystrdys hi of $14.80
LoL....and the worst is yet to come Wait for it ; )
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 20, 2024 12:18pm
XCUR...here is a perfect example of how "Share Structure"...
is so relevant to share price appreciation. It boils down to the fact that it doesn't matter what the Company does for it's business ; ) Make note: This Co has Zero Revenue and is
...more
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Nov 20, 2024 12:10pm
RE:XCUR Just got a buy alert from Tim Skyes Last call DRUG
Well that was timely advice looking back in hindsight and witnessing todays volume & price action!! Trade as high as $14.80 on 15 million shares Pretty amazing
(5)
•••
10QKing
X
Post by
10QKing
on Oct 15, 2024 11:24am
XCUR Just got a buy alert from Tim Skyes Last call DRUG
XCUR Just got a buy alert from Tim Skyes Last call DRUG
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 17, 2024 9:15am
RE:XCUR....big vol & price action yesterday !!!!
Make note....... DGP Co.Ltd acquired shres at $3.00 !!!!
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 17, 2024 9:14am
XCUR....big vol & price action yesterday !!!!
And while I was away the share price ramped up to $2.67 and the volume increased to 19 million shares traded....Nice ; ) Here is the reason..... DGP Co. Ltd. of South Korea acquired XCUR shares for
...more
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 13, 2024 12:27pm
XCUR ....resurrection shuffle???
Yep....on watch
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 26, 2024 9:09am
New Press Release - Exicure, Inc. Announces 1-for-5 Reverse Stock Split
Exicure, Inc. (Nasdaq: XCUR, “the Company”) today announced that it will effect a 1-for-5 reverse stock split of its outstanding shares of common stock (the “Reverse Stock Split”). The Company expects that the Reverse Stock Split will become effective at 5:00 pm on Tuesday, August 27, 2024, and...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 19, 2024 10:31am
New Press Release - Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting
Exicure, Inc. (Nasdaq: XCUR, the "Company") announced today that its Special Meeting of Stockholders (the "Special Meeting"), initially scheduled for August 15, 2024 and adjourned and reconvened on August 19, 2024, has been adjourned again for the purpose of soliciting additional votes with...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 15, 2024 10:31am
New Press Release - Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting
Exicure, Inc. (Nasdaq: XCUR, the "Company") announced today that its Special Meeting of Stockholders (the "Special Meeting") scheduled for and convened on August 15, 2024 has been adjourned for the purpose of soliciting additional votes with respect to the proposal described in the Company's...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 13, 2024 4:02pm
New Press Release - Exicure, Inc. Reports Second Quarter 2024 Financial Results
Exicure, Inc. (Nasdaq: XCUR, the "Company"), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company announced a significant reduction in force, suspension of...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 08, 2024 4:39pm
New Press Release - Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics
Anna Chukaeva has been appointed as Senior Vice President, Head of Corporate Development and Bioinformatics of Exicure, Inc. (“the Company”) (Nasdaq: XCUR). Anna will spearhead investments, acquisitions, and strategic partnerships. She will also push into leveraging data and AI for drug discovery...
read article.
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 2:54am
Exicure, Inc. (NASDAQ:XCUR): Exploring Strategic Alternative
https://beyondspx.com/2024/08/02/exicure-inc-nasdaqxcur-exploring-strategic-alternatives-amidst-significant-challenges/
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 01, 2024 4:05pm
New Press Release - Exicure, Inc. Receives Positive Listing Determination from Nasdaq
Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR), announced today that on July 31, 2024, the Company received formal notice that the Nasdaq Hearings Panel (“Panel”) has determined to continue the Company’s listing subject to the Company evidencing compliance with all applicable criteria...
read article.
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Are PGM mining stocks an attractive area for your next portfolio allocation?
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments